Page last updated: 2024-09-05

tolvaptan and Dilatation, Pathologic

tolvaptan has been researched along with Dilatation, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flores, E; Ibrahim, H; Katz, S; Konstam, MA; Koshkarian, G; Kronenberg, MW; McGrew, FA; O'Brien, T; Orlandi, C; Udelson, JE; Zimmer, C	1

Trials

1 trial(s) available for tolvaptan and Dilatation, Pathologic

Article	Year
Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. Journal of the American College of Cardiology, 2007, Jun-05, Volume: 49, Issue:22 Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Dilatation, Pathologic; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Receptors, Vasopressin; Systole; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling	2007

Article

Year

Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.

Journal of the American College of Cardiology, 2007, Jun-05, Volume: 49, Issue:22

Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Dilatation, Pathologic; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Receptors, Vasopressin; Systole; Tolvaptan; Ventricular Function, Left; Ventricular Remodeling

2007